Trial intelligence / Profile preview

Doxycycline for asthma-like infection

IRCT20220412054507N1Phase 3Completed

Sponsor
Islamic Azad University
Start
Apr 2021
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of doxycycline in asthma (2 arms), sponsored by Islamic Azad University. Primary endpoints: Wheezing at physical examination, Asthma attacks and 3 more. Started Apr 2021; status: completed.

02

Drugs

doxycycline
03

Conditions

asthma

Beyond the preview

Go deeper on IRCT20220412054507N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20220412054507N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call